Royal Bank Of Canada Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

Nov 05, 2024
BUY
$902.69 - $993.35 $180,538 - $198,670
200 New
200 $192,000
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $180,538 - $198,670
200 New
200 $192,000
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $3.74 Million - $4.55 Million
5,500 New
5,500 $4.52 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
82.7M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email